GISEA/OEG INTERNATIONAL SYMPOSIUM TORINO, MARZO 2016 TORINO INCONTRA CENTRO CONGRESSI - TORINO

Transcript

1 GISEA/OEG INTERNATIONAL SYMPOSIUM TORINO, MARZO 2016 TORINO INCONTRA CENTRO CONGRESSI - TORINO RATIONALE A number of European countries have set-up biologics registries to follow cohorts of patients treated with TNF-targeted therapies and record their characteristics and clinical course over time. As we are aware, these registries have begun to provide valuable insights into the

2 optimal treatment of various rheumatic conditions that can and should be used to inform clinical decision making and to provide also important safety informations. The educational aims of this congress are to: Highlight the role of national biologic registers as a source of long-term, real-life data and assess the implications for clinical practice; Review the long-term effectiveness and maintenance on therapy data from national biologic registers; Comparing data from national biologic registers on RA and Spondyloarthritides; To stress the value of early diagnosis and treatments; Reanalyze the ultrasonography as a useful diagnostic tool in managing these diseases; Consider the safety data emerging from national biologic registers with a particular focus on serious infections, lymphoma and solid tumors. Destinatari della iniziativa: 100 Medici Chirurghi Specialisti in Reumatologia

3 GIOVEDÌ 10 MARZO ,00 Lunch 12,45 13,00 Apertura lavori e saluto delle autorità 13,00 13,30 Sponsored Lecture (No ECM): Golimumab in Real Life Setting: New emerging evidences Relatore: Florenzo Iannone, Bari 13,30 14,00 Sponsored Lecture (No ECM): I Dati Real Life nei Farmaci Biologici Relatore: Michele Lattarulo, Bari Moderatore: Enrico Fusaro, Torino SESSIONE I AXIAL SPONDYLOARTHRITIS CHAIRMAN: Roberto Caporali, Antonio Carletto 14,00 14,15 Non radiographic axial SpA: an early phase of ankylosing spondylitis or a different disease? (Xenofon Baraliakos, Germany) 14,15 14,30 Spontaneous, drug-induced, and drug-free remission in axial spondyloarthritis (Ennio Favalli, Milano) 14,30 14,45 The role of non-pharmacologic treatment in Axial SpA (ankylosing spondylitis) (Elisa Gremese, Roma) 14,45 15,00 Discussion

4 SESSIONE II EXTRA ARTICULAR COMORBIDITIES CHAIRMAN: Fabiola Atzeni, Clodoveo Ferri 15,00 15,15 Which index and questionnaires for evaluating comorbidities in inflammatory arthritis? (Helga Radner, Austria) 15,15 15,30 Ocular findings in Spondyloarthritis (Cimino L, Reggio Emilia) 15,30 15,45 Cardiovascular manifestations in Spondyloarthritis (Szekanecz Z, Hungary) 15,45 16,00 Discussion 16,00 16,15 Break 16,15 16,45 Sponsored Lecture (No ECM): The choice of abatacept in early rapidly progressing patient: lesson learned from trials and real life data Relatore: Rosario Foti, Catania Moderatore: Giovanni Lapadula, Bari 16,45 17,15 Sponsored Lecture (No ECM): The importance of axspa beyond sacroiliitis: solution for a holistic approach Relatore: Gianfranco Ferraccioli, Roma Moderatore: Alessandro Mathieu, Cagliari 17,15 17,45 Sponsored Lecture (No ECM): Consensus tra Reumatologi e Radiologi per l imaging dell Axial SpA Relatori: Riccardo Faletti, Torino; Enrico Fusaro, Torino; Raffaele Pellerito, Torino; Moderatore: Francesco Trotta, Ferrara

5 SESSIONE III NEW DRUGS (IN SPA) CHAIRMAN:Ennio Favalli, Giuseppe Passiu 17,45 18,00 New insights in the treatment of psoriatic disease: update on phase II/III trials (Paolo Gisondi, Verona) 18,00 18,15 One step beyond TNF blockade: the IL 12/23 and IL 17 pathway in the treatment of SpA (ankylosing spondylitis) (Luca Idolazzi, Verona) 18,15 18,30 The present and the future of preventing damage progression in ankylosing spondylitis (Ennio Lubrano Di Scorpaniello, Campobasso) 18,30 18,45 Discussion

6 VENERDÌ 11 MARZO ,00 09,30 Sponsored Lecture (No ECM): What does MTX mean in 2016? Relatore: Monica Todoerti, Pavia Moderatore: Francesco Paolo Cantatore, Foggia 09,30 10,00 Sponsored Lecture (No ECM): The role of IL 6 inhibition in RA: tocilizumab in the treatment algorithm Relatore: Luigi Sinigaglia, Milano Moderatore: Giovanni Lapadula, Bari 10,00 10,15 Presentazione Progetto Medicina Comunicazionale e Relazionale (Progetto rivolto all acquisizione di competenze e conoscenze in ambito di comunicazione medico paziente) Relatore: Rosario Gagliardi, Lecce 10,15 10,30 Break SESSIONE I PSORIATIC ARTHRITIS CHAIRMAN: Piercarlo Sarzi Puttini, Roberta Ramonda 10,30 10,45 New insights in the pathogenesis of PsA (PSORIATIC ARTHRITIS) (Alberto Cauli, Cagliari) 10,45 11,15 Lecture Psoriatic arthritis: criteria and therapeutic algorithms (Antonio Marchesoni, Milano) 11,15 11,30 Idea Project: Diagnostic algorithm and management of PsA (PSORIATIC ARTHRITIS) (Giovanni Lapadula, Bari)

7 11,30 12,00 Lecture Psoriatic arthritis and real-life: data from European registries (Tore Kvien, Oslo) 12,00 12,15 Psoriatic arthritis and real-life: data from GISEA registry (Leonardo Punzi, Padova) 12,15 12,30 Discussion 12,30 14,00 Lunch SESSIONE II EARLY UNDIFFERENTIATED AND RHEUMATOID ARTHRITIS CHAIRMAN: Elisa Gremese, Carlo Maurizio Montecucco 14,00 14,15 Which therapeutic interventions in patients with early undifferentiated arthritis to delay or halt disease progression? (Bruno Jean Fautrel, Parigi) 14,15 14,30 Personalized medicine: genetic and epigenetic markers (Stefano Alivernini, Roma) 14,30 14,45 Corticosteroids role in Rheumatoid Arthritis management: data from clinical trials and real life (GISEA registry) (Roberto Caporali, Pavia) 14,45 15,00 Interstitial lung disease in RA (Rheumatoid Arthritis): prevalence, prognosis and early diagnosis (Andreina Manfredi, Modena) 15,00 15,15 Discussion 15,15 16,00 Lecture Target terapeutici intra ed extra cellulari: pro e contro Relatori: Fabrizio Conti, Roma Gianfranco Ferraccioli, Roma Moderatori: Raffaele Pellerito, Roma Enrico Fusaro, Roma

8 SESSIONE III REACTIVE ARTHRITIS AND ENTEROPATHIC ARTHRITIS CHAIRMAN: Marco Sebastiani, Giovanni Triolo 16,00 16,15 Reactive arthritis: from anti-infiammatory drugs to DMARDs and biologics (Fabiola Atzeni, Milano) 16,15 16,30 Epidemiology and clinical course of IBD associated SpA (ankylosing spondylitis) (Carlo Salvarani, Reggio Emilia) 16,30 16,45 Need for integrated approach for IBD associated SpA (ankylosing spondylitis) patient management (Paolo Gionchetti, Bologna) 16,45 17,00 Discussion SESSIONE IV IMAGING INTEGRATO NEL COINVOLGIMENTO ASSIALE DELLE SPONDILOARTRITI CHAIRMAN:Fausto Salaffi, Giuseppe Paolazzi 17,00 17,15 Lesioni elementari in radiologia convenzionale (Fausto Salaffi, Jesi) 17,15 17,30 Ruolo della risonanza magnetica e della tomografia computerizzata (Marina Carotti, Jesi) 17,30 17,45 Discussion 17,45 Fine ECM TEST